News & Updates

Use of semaglutide and, to a lesser extent, liraglutide is associated with significantly lower risk of worsening mental illness in patients with depression or anxiety vs non-use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a national cohort study has found.

A Hong Kong–Chinese (HK-Chinese) model achieves satisfactory accuracy in predicting 10-year atherosclerotic cardiovascular disease (ASCVD) risk in Chinese patients with schizophrenia-spectrum disorders, according to a population-based cohort study.